Erlotinib, Vandetanib, Lapatinib, and Axitinib are FDA-approved drugs that affect protein tyrosine kinases, inhibit EGFR and VEGFR, and are used to treat cancers such as lung cancer, breast cancer, thyroid cancer, and melanoma50. The gene discussed is EGFR; the disease is cancer.